Organ-on-Chip Market By Type (Heart on chip, Human on chip, Intestine on chip, Kidney on chip, Liver on chip, Lung on chip): Global Opportunity Analysis and Industry Forecast, 2020-2030

Organ-on-Chip Market By Type (Heart on chip, Human on chip, Intestine on chip, Kidney on chip, Liver on chip, Lung on chip): Global Opportunity Analysis and Industry Forecast, 2020-2030

The global organ-on-chip market was valued at $103.44 million in 2020, and is estimated to reach $1,559.2 million by 2030, growing at a CAGR of 31.1% from 2021 to 2030. 

Organ-on-chip is designed to replicate the natural physiology and mechanical stress that cells in the human body encounter.

The chips have real human cells lining them, and their tiny fluidic channels mimic blood and air movement in the human body. The chips flexibility allows them to mimic breathing patterns and muscle contractions. Each organ chip, including the lung, liver, intestine, or brain, is approximately the size of an battery that is typically used in small electronic devices. . Such devices produce multiple levels of tissues and organ functionalities, which are not possible using conventional 2D and 3D culture systems. Organ-on-chip offers a wide range of applications such as diseases modelling, patient stratification, and phenotypic screening. Researchers can see the organ's operation, behavior, and response at the cellular and molecular level because to the chip's transparency.

This market is majorly driven by increase in prevalence of the chronic disease across the globe, which, in turn, increases the demand for medications, leading to drug discovery, drug development, and animal testing. However, organ-on-chips are looked on as an alternative for animal testing due to stringent regulatory guidelines and its complexity. Wide availability of 3D models for in vitro testing ,including lung-on-chip, heart-on-chip, liver-on-chip, and brain-on-chip is significantly driving the growth of the market.

Furthermore, in May 2021, the U.S. Food and Drug Administration (FDA) extendedits research collaboration with CN Bio Innovations Limited, one of the leading developers of single and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, for another three years to investigate the lung-on-a-chip model for inhaled drug evaluation applications.

Furthermore, growth in demand for personalized medicine, rise in pharmaceutical & biotechnology R&D, and government funding for various drugs, clinical trials for novel entities, and repurposing of the drugs are  expected to drive the organ-on-chip market in the forecast period.

Market players have invested in developing organ-on-chip products for lung, heart, kidney, brain, liver, and gut that can aid in several disease treatments. For instance, Nortis Inc. offers ParVivo microfluidic chips system is the world’s first and only pre-seeded chip platform, where researchers can purchase chips that have engineered functional living human tissues on them. Emulate Inc., one of the leaders in the organ-on-chip market industry offers colon-chip, duodenum-chip, brain-chip, lung-chip, kidney-chip, and liver-chip to investigate its mechanisms and evaluate its drug efficacy. These wide range of products offering by market players have further increased accessibility of organ-on-chip across different regions, thus fueling the market growth.

However, high cost of the organ chip device and the development of organ-on-chip technology is still in its nascent stage, and is expected to restrain growth of the market. Furthermore, presence of a variety of products in the pipeline and high market potential in untapped emerging economies are anticipated to serve as attractive opportunities for the market growth during the forecast period. Conversely, considerable rise in healthcare expenditure across the globe led to rise in the market growth. Emerging economies possess high potential for organ-on-chip. Growth in awareness for animal safety during clinical trials and stringent guidelines by regulatory authorities for these trials surge the organ-on- chip market and is being regarded as a promising technology for the alternative to animal testing and is expected to boost the organ-on-chip market size.

The organ-on-chip market is segmented on the basis of type, and region. Depending on type, it is classified into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lung-on-chip. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players profiled in the report are AxoSim Technologies LLC, BICO Group AB(Visikol), CN Bio Innovations Limited, Elveflow, Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the organ-on-chip market analysis from 2020 to 2030 to identify the prevailing organ-on-chip market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the organ-on-chip market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global organ-on-chip market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Type

Heart on chip
Human on chip
Intestine on chip
Kidney on chip
Liver on chip
Lung on chip

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

Key Market Players

AxoSim Technologies LLC
BICO Group AB(Visikol)
CN Bio Innovations Limited
Elveflow
Emulate, Inc.
Insphero AG
Mimetas B.V.
Nortis Inc.
Organovo Holdings, Inc.
Tara Biosystems


CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ORGAN-ON-CHIP MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Heart on chip
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Human on chip
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Intestine on chip
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Kidney on chip
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Liver on chip
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Lung on chip
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: ORGAN-ON-CHIP MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Type
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Type
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Type
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Type
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Type
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Type
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Type
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Type
5.3.3.4 Rest of Europe
5.3.3.4.1 Market size and forecast, by Type
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Type
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Type
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Type
5.4.3.3 India
5.4.3.3.1 Market size and forecast, by Type
5.4.3.4 Australia
5.4.3.4.1 Market size and forecast, by Type
5.4.3.5 Rest of Asia-Pacific
5.4.3.5.1 Market size and forecast, by Type
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Type
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Latin America
5.5.3.1.1 Market size and forecast, by Type
5.5.3.2 Middle East
5.5.3.2.1 Market size and forecast, by Type
5.5.3.3 Africa
5.5.3.3.1 Market size and forecast, by Type
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 AxoSim Technologies LLC
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 BICO Group AB(Visikol)
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 CN Bio Innovations Limited
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Elveflow
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Emulate, Inc.
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Insphero AG
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Mimetas B.V.
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Nortis Inc.
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Organovo Holdings, Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Tara Biosystems
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 2. ORGAN-ON-CHIP MARKET REVENUE, FOR HEART ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 3. ORGAN-ON-CHIP MARKET HEART ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ORGAN-ON-CHIP MARKET REVENUE, FOR HUMAN ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 5. ORGAN-ON-CHIP MARKET HUMAN ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. ORGAN-ON-CHIP MARKET REVENUE, FOR INTESTINE ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 7. ORGAN-ON-CHIP MARKET INTESTINE ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. ORGAN-ON-CHIP MARKET REVENUE, FOR KIDNEY ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 9. ORGAN-ON-CHIP MARKET KIDNEY ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. ORGAN-ON-CHIP MARKET REVENUE, FOR LIVER ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 11. ORGAN-ON-CHIP MARKET LIVER ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. ORGAN-ON-CHIP MARKET REVENUE, FOR LUNG ON CHIP, BY REGION , 2020-2030,($MILLION)
TABLE 13. ORGAN-ON-CHIP MARKET LUNG ON CHIP BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. ORGAN-ON-CHIP MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 15. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 16. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. U.S. ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 18. CANADA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 19. MEXICO ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 20. EUROPE ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 21. EUROPE ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. GERMANY ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 23. FRANCE ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 24. U.K. ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 25. REST OF EUROPE ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 26. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 27. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 28. JAPAN ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 29. CHINA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 30. INDIA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 31. AUSTRALIA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 32. REST OF ASIA-PACIFIC ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 33. LAMEA ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 34. LAMEA ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. LATIN AMERICA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 36. MIDDLE EAST ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 37. AFRICA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
TABLE 38.AXOSIM TECHNOLOGIES LLC: COMPANY SNAPSHOT
TABLE 39.AXOSIM TECHNOLOGIES LLC: OPERATING SEGMENTS
TABLE 40.AXOSIM TECHNOLOGIES LLC: PRODUCT PORTFOLIO
TABLE 41.AXOSIM TECHNOLOGIES LLC: NET SALES,
TABLE 42.AXOSIM TECHNOLOGIES LLC: KEY STRATERGIES
TABLE 43.BICO GROUP AB(VISIKOL): COMPANY SNAPSHOT
TABLE 44.BICO GROUP AB(VISIKOL): OPERATING SEGMENTS
TABLE 45.BICO GROUP AB(VISIKOL): PRODUCT PORTFOLIO
TABLE 46.BICO GROUP AB(VISIKOL): NET SALES,
TABLE 47.BICO GROUP AB(VISIKOL): KEY STRATERGIES
TABLE 48.CN BIO INNOVATIONS LIMITED: COMPANY SNAPSHOT
TABLE 49.CN BIO INNOVATIONS LIMITED: OPERATING SEGMENTS
TABLE 50.CN BIO INNOVATIONS LIMITED: PRODUCT PORTFOLIO
TABLE 51.CN BIO INNOVATIONS LIMITED: NET SALES,
TABLE 52.CN BIO INNOVATIONS LIMITED: KEY STRATERGIES
TABLE 53.ELVEFLOW: COMPANY SNAPSHOT
TABLE 54.ELVEFLOW: OPERATING SEGMENTS
TABLE 55.ELVEFLOW: PRODUCT PORTFOLIO
TABLE 56.ELVEFLOW: NET SALES,
TABLE 57.ELVEFLOW: KEY STRATERGIES
TABLE 58.EMULATE, INC.: COMPANY SNAPSHOT
TABLE 59.EMULATE, INC.: OPERATING SEGMENTS
TABLE 60.EMULATE, INC.: PRODUCT PORTFOLIO
TABLE 61.EMULATE, INC.: NET SALES,
TABLE 62.EMULATE, INC.: KEY STRATERGIES
TABLE 63.INSPHERO AG: COMPANY SNAPSHOT
TABLE 64.INSPHERO AG: OPERATING SEGMENTS
TABLE 65.INSPHERO AG: PRODUCT PORTFOLIO
TABLE 66.INSPHERO AG: NET SALES,
TABLE 67.INSPHERO AG: KEY STRATERGIES
TABLE 68.MIMETAS B.V.: COMPANY SNAPSHOT
TABLE 69.MIMETAS B.V.: OPERATING SEGMENTS
TABLE 70.MIMETAS B.V.: PRODUCT PORTFOLIO
TABLE 71.MIMETAS B.V.: NET SALES,
TABLE 72.MIMETAS B.V.: KEY STRATERGIES
TABLE 73.NORTIS INC.: COMPANY SNAPSHOT
TABLE 74.NORTIS INC.: OPERATING SEGMENTS
TABLE 75.NORTIS INC.: PRODUCT PORTFOLIO
TABLE 76.NORTIS INC.: NET SALES,
TABLE 77.NORTIS INC.: KEY STRATERGIES
TABLE 78.ORGANOVO HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 79.ORGANOVO HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 80.ORGANOVO HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 81.ORGANOVO HOLDINGS, INC.: NET SALES,
TABLE 82.ORGANOVO HOLDINGS, INC.: KEY STRATERGIES
TABLE 83.TARA BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 84.TARA BIOSYSTEMS: OPERATING SEGMENTS
TABLE 85.TARA BIOSYSTEMS: PRODUCT PORTFOLIO
TABLE 86.TARA BIOSYSTEMS: NET SALES,
TABLE 87.TARA BIOSYSTEMS: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.ORGAN-ON-CHIP MARKET SEGMENTATION
FIGURE 2.ORGAN-ON-CHIP MARKET,2020-2030
FIGURE 3.ORGAN-ON-CHIP MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.ORGAN-ON-CHIP MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.ORGAN-ON-CHIP MARKET,BY TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF HEART ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF HUMAN ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTESTINE ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF KIDNEY ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LIVER ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF LUNG ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
FIGURE 18.ORGAN-ON-CHIP MARKET BY REGION,2020
FIGURE 19.U.S. ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 20.CANADA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 21.MEXICO ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 22.GERMANY ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 23.FRANCE ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 24.U.K. ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 25.REST OF EUROPE ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 26.JAPAN ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 27.CHINA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 28.INDIA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 29.AUSTRALIA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 30.REST OF ASIA-PACIFIC ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 31.LATIN AMERICA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 32.MIDDLE EAST ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 33.AFRICA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
FIGURE 34. TOP WINNING STRATEGIES, BY YEAR
FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 38.COMPETITIVE DASHBOARD
FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 40.AXOSIM TECHNOLOGIES LLC.: NET SALES ,($MILLION)
FIGURE 41.BICO GROUP AB(VISIKOL).: NET SALES ,($MILLION)
FIGURE 42.CN BIO INNOVATIONS LIMITED.: NET SALES ,($MILLION)
FIGURE 43.ELVEFLOW.: NET SALES ,($MILLION)
FIGURE 44.EMULATE, INC..: NET SALES ,($MILLION)
FIGURE 45.INSPHERO AG.: NET SALES ,($MILLION)
FIGURE 46.MIMETAS B.V..: NET SALES ,($MILLION)
FIGURE 47.NORTIS INC..: NET SALES ,($MILLION)
FIGURE 48.ORGANOVO HOLDINGS, INC..: NET SALES ,($MILLION)
FIGURE 49.TARA BIOSYSTEMS.: NET SALES ,($MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings